Epstein Secrets

to state and local governments, school funding and Republican insistence on a liability shield for employers." The New Ynrk TIMPc (10/22, Cochrane, Broadwater, 18.61M) says Pelosi "was noncommittal on Thursday about bringing a stimulus measure to the House floor for a vote before the November election." L

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

or employers." The New York Times <https://vvww.nytimes.com/2020/10/22/business/stimulus-deal-may-wait-until-after- election.html> (10/22, Cochrane, Broadwater, 18.61 M) says Pelosi "was noncommittal on Thursday about bringing a stimulus measure to the House floor for a vote before the November election." L

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

to state and local governments, school funding and Republican insistence on a liability shield for employers." The New York Times (10/22, Cochrane, Broadwater, 18.61M) says Pelosi "was noncommittal on Thursday about bringing a stimulus measure to the House floor for a vote before the November election." L

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug